Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)

Conditions:   Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Behavioral: Education
Sponsors:   University Hospital, Basel, Switzerland;   University of Basel
Recruiting - verified April 2017

Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy

Conditions:   Anticoagulant-induced Bleeding;   Dental Diseases
Intervention:   Procedure: simple dental extraction
Sponsor:   University of Trieste
Recruiting - verified April 2017

Post-Market Clinical Follow-up Study With ASPIREX®S to Assess the Safety and Effectiveness in the Treatment of DVT

Conditions:   Deep Vein Thrombosis;   Bypass Complication;   Dialysis Shunt;   Stent Occlusion
Intervention:  
Sponsor:   Straub Medical AG
Recruiting - verified April 2017

Evaluation of the Intra- and Post- Operative Bleeding After Periodontal Debridement in Direct Anticoagulant Patients

Conditions:   Anticoagulant-induced Bleeding;   Periodontal Diseases
Intervention:   Procedure: periodontal debridement
Sponsor:   University of Trieste
Recruiting - verified April 2017

Apixaban in Preventing Secondary Cancer Related Blood Clots in Cancer Patients Who Have Completed Anticoagulation Therapy

Conditions:   Deep Vein Thrombosis;   Malignant Neoplasm;   Metastatic Malignant Neoplasm;   Pulmonary Embolism
Intervention:   Drug: Apixaban
Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI)
Not yet recruiting - verified April 2017

Incidence of Venous Thromboembolism in Patients Undergoing Major Esophageal Resection

Conditions:   Venous Thromboembolism;   Thoracic Surgery;   Esophageal Cancer
Intervention:  
Sponsor:   McMaster University
Not yet recruiting - verified April 2017

Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF)

Condition:   Idiopathic Pulmonary Fibrosis
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2017

Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs

Conditions:   Leg Ulcer;   Veins, Varicose;   Venous Ulcer;   Reflux;   Venous Reflux;   Venous Leg Ulcer;   Varicose Veins;   Varicose Ulcer;   Varicose Veins Leg
Intervention:   Drug: Polidocanol Endovenous Microfoam (PEM)
Sponsors:   OhioHealth;   BTG International Inc.
Recruiting - verified April 2017

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Condition:   Anaemia
Interventions:   Drug: Daprodustat;   Drug: rhEPO;   Drug: Placebo;   Drug: Iron therapy
Sponsor:   GlaxoSmithKline
Recruiting - verified April 2017

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Condition:   Anaemia
Interventions:   Drug: Daprodustat;   Drug: Darbepoetin alfa;   Drug: Placebo;   Drug: Iron Therapy
Sponsor:   GlaxoSmithKline
Recruiting - verified April 2017

Study to Assess Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-level Deep Venous Thrombosis (DVT)

Condition:   Deep Venous Thrombosis
Interventions:   Drug: GMI-1271;   Drug: Enoxaparin Sodium (Lovenox®)
Sponsors:   GlycoMimetics Incorporated;   University of Michigan
Completed - verified April 2017

A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer

Condition:   Venous Thrombosis and Pulmonary Embolism
Intervention:   Drug: Rivaroxaban (Xarelto, BAY 59-7939)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified April 2017

Global Study Comparing a rivAroxaban-based Antithrombotic Strategy to an antipLatelet-based Strategy After Transcatheter aortIc vaLve rEplacement to Optimize Clinical Outcomes

Condition:   Transcatheter Aortic Valve Replacement
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Acetylsalicylic acid;   Drug: Clopidogrel
Sponsors:   Bayer;   Janssen Research & Development, LLC
Recruiting - verified April 2017

Evaluation of Soluble Fibrin in Thrombosis Exclusion

Conditions:   Pulmonary Embolism (PE);   Deep Vein Thrombosis (DVT)
Intervention:   Other: Soluble Fibrin
Sponsors:   Diagnostica Stago R&D;   Hôpital Louis Mourier;   Hopital Lariboisière
Recruiting - verified April 2017

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
Sponsors:   Bayer;   Janssen Scientific Affairs, LLC
Recruiting - verified April 2017

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Pegylated (PEG) L-Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified March 2017

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Placebo
Sponsors:   AstraZeneca;   FibroGen
Active, not recruiting - verified April 2017

Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease, on Dialysis

Condition:   Anemia
Interventions:   Drug: Roxadustat;   Drug: Epoetin alfa
Sponsors:   AstraZeneca;   FibroGen
Recruiting - verified April 2017

Role of a Novel Exercise Program to Prevent Post-thrombotic Syndrome

Condition:   Acute Deep Vein Thrombosis
Interventions:   Other: Exercise;   Other: Control
Sponsors:   VA Office of Research and Development;   University of Maryland
Recruiting - verified April 2017

Personalized Medicine Decision-Making in a Virtual Clinical Setting

Conditions:   Deep Vein Thrombosis;   Blood Clots
Intervention:  
Sponsor:   National Human Genome Research Institute (NHGRI)
Recruiting - verified March 10, 2017

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Conditions:   Hypercortisolism;   Cushing Syndrome
Interventions:   Procedure: Adrenalectomy;   Other: Observation
Sponsors:   National Cancer Institute (NCI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   CC-OADRIS
Recruiting - verified January 24, 2017

Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study

Condition:   Deep Vein Thrombosis
Interventions:   Device: geko™ post-surgery for 48hrs then 4hrs/day until discharge.;   Device: TEDS post-surgery for 48hrs then 4hrs/day until discharge.
Sponsor:   Firstkind Ltd
Recruiting - verified October 2016

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Condition:   Anticoagulation
Intervention:   Drug: Apixaban
Sponsors:   Bristol-Myers Squibb;   Pfizer
Recruiting - verified August 2016

Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis

Condition:   Thrombosis
Intervention:   Other: No intervention
Sponsor:   University Hospital, Basel, Switzerland
Terminated - verified April 2017

Feasibility Study of Exercise in Patients With Leg Blood Clots

Condition:   Deep Vein Thrombosis
Intervention:   Other: Exercise
Sponsor:   University of Oklahoma
Completed - verified April 2017

Blood Markers of Inflammation, Blood Clotting and Blood Vessel Function in HIV-infected Adults

Condition:   HIV
Intervention:  
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified January 19, 2017

Hip Fracture Study of GSK576428 (Fondaparinux Sodium)

Condition:   Thromboembolism
Intervention:   Drug: Fondaparinux
Sponsor:   GlaxoSmithKline
Completed - verified April 2017

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

Condition:   Thrombosis, Venous
Intervention:   Drug: Fondaparinux
Sponsor:   GlaxoSmithKline
Completed - verified April 2017